The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression
Open accessAbstract
Previous studies demonstrated that antidepressant treatment increases the expression of brain-derived neurotrophic factor (BDNF) in rat hippocampus. The present study was conducted to test the hypothesis that BDNF in the hippocampus produces an antidepressant effect in behavioral models of depression, the learned helplessness (LH) and forced swim test (FST) paradigms. A single bilateral infusion of BDNF into the dentate gyrus of hippocampus produced an antidepressant effect in both the LH and FST that was comparable in magnitude with repeated systemic administration of a chemical antidepressant. These effects were observed as early as 3 d after a single infusion of BDNF and lasted for at least 10 d. Similar effects were observed with neurotrophin-3 (NT-3) but not nerve growth factor. Infusions of BDNF and NT-3 did not influence locomotor activity or passive avoidance. The results provide further support for the hypothesis that BDNF contributes to the therapeutic action of antidepressant treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, intrahippocampal infusion of BDNF was shown to mitigate stress-induced neurogenic impairments [115] and promote neurogenesis [116].”
From Chronic Stress-Associated Depressive Disorders: The Impact of HPA Axis Dysregulation and Neuroinflammation on the Hippocampus—A Mini Review (2025) · cites this paper as [115]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Subsequent studies showed that a single bilateral infusion of BDNF into the ventricles or directly into the hippocampus is sufficient to induce a relatively rapid and sustained antidepressant-like effect.”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Shirayama et al., 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“direct administration of BDNF into the rodent brain has been shown to alleviate several depressive phenotypes, curb addiction, and enhance fear extinction (130–133)”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [131]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was also discovered that administering BDNF to the dentate gyrus and CA3 regions of the hippocampus produced antidepressant effects within a few days, primarily through TrkB activation and the MEK-ERK signaling pathway [45].”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In rodents, direct infusion of BDNF in the hippocampus (Deltheil et al. 2008, 2009; Shirayama et al. 2002; Sirianni et al. 2010) and midbrain (Siuciak et al. 1997) showed antidepressant-like effects.”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Shirayama et al. 2002
The cited source says what the claim attributes to it.
In the citing paper
“Subsequent work showed that a single bilateral infusion of a low dose of BDNF directly into the DG or CA3, but not CA1, region of the hippocampus was sufficient to induce an antidepressant-like effect within three days (Shirayama et al., 2002), suggesting that these regions may be key regions for antidepressant effects acting through BDNF.”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Shirayama et al., 2002
The cited source says what the claim attributes to it.
In the citing paper
“Rather surprisingly, this study also noted that BDNF produced an antidepressant effect for up to 10 days after the infusion, well past the time frame of the degradation of the protein, suggesting that BDNF may be triggering a sustained plasticity mechanism to mediate the long-term antidepressant effects.”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Shirayama et al., 2002
The cited source says what the claim attributes to it.
In the citing paper
“In this latter study, the antidepressant effects of BDNF were suggested to be mediated by TrkB activation of mitogen-activated protein kinase kinase (MEK), acting through the extracellular signal-regulated protein kinase (ERK) pathway.”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Shirayama et al., 2002
The cited source says what the claim attributes to it.
In the citing paper
“As previously discussed, bilateral BDNF-infusions into the hippocampus or the ventricles induces antidepressant-like effects in preclinical animal models that can persist for several days (Shirayama et al., 2002; Siuciak et al., 1997).”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Shirayama et al., 2002
In the citing paper
“With regards to depression, systemic or intra-hippocampal administration of BDNF exerts antidepressant-like effects 153–155, and over-expression of BDNF in the hippocampus leads to resilience to chronic stress 156.”
From Mechanisms of ketamine action as an antidepressant (2018) · cites this paper as [154]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,118
AChE-stained horizontal sections of the rat brain in stereotaxic coordinates
Paxinos, G., WATSON, C. R. R., & Emson, P. C. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90021-7 · Cited by 4,501
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Self-citationNibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
Self-citationHippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932
Neurotrophins as synaptic modulators
Poo, M.-M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35049004 · Cited by 1,775
Cited by
Sorted by citations
Items 201–211 of 211
Activation of postsynaptic 5-HT1A receptors improve stress adaptation
Zhou, J., Cao, X., Mar, A. C., Ding, Y.-Q., Wang, X., Li, Q., & Li, L. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3350-z · Cited by 36
Eremin, K. O., Kudrin, V. S., Saransaari, P., Oja, S. S., Grivennikov, I. A., Myasoedov, N. F., & Rayevsky, K. S. (2005) · Neurochemical Research · doi:10.1007/s11064-005-8826-8 · Cited by 29
Li, A., Yau, S.-Y., Machado, S., Wang, P., Yuan, T.-F., & So, K.-F. (2019) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527318666190308102804 · Cited by 27
Boulle, F., Velthuis, H., Koedam, K., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., Gabriel, C., Mocaer, E., Franc, B., Rognan, D., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.003 · Cited by 24
Greenwood, B. N., Strong, P. V., & Fleshner, M. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.03.012 · Cited by 24
Zemdegs, J., Rainer, Q., Grossmann, C. P., Rousseau-Ralliard, D., Grynberg, A., Ribeiro, E., & Guiard, B. P. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00974 · Cited by 23
Vakhitova, Y. V., Kalinina, T. S., Zainullina, L. F., Lusta, A. Y., Volkova, A. V., Kudryashov, N. V., Gudasheva, T. A., Shimshirt, A. A., Kadnikov, I. A., Voronin, M. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413381 · Cited by 21
Identification and Characterization of Compounds That Potentiate NT-3-Mediated Trk Receptor Activity
Lewis, M. A., Hunihan, L., Franco, D., Robertson, B., Palmer, J., Laurent, D. R. S., Balasubramanian, B. N., Li, Y., & Westphal, R. S. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020255 · Cited by 21
Study on the comorbid mechanisms of sarcopenia and late-life depression
Wu, J., Tang, J., Huang, D., Wang, Y., Zhou, E., Ru, Q., Xu, G., Chen, L., & Wu, Y. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115538 · Cited by 12
Wang, N., Zhu, S., Chen, S., Zou, J., Zeng, P., & Tan, S. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0147 · Cited by 12
Aykaç, A., Öncül, Ş., & Onur, R. (2018) · Marmara Pharmaceutical Journal · doi:10.12991/mpj.2018.56 · Cited by 2
Metadata
- Authors
- Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S.
- Affiliations
- Yale University (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2002-04-15
- Volume
- 22
- Issue
- 8
- Pages
- 3251-3261
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6757539
- OpenAlex
- W2140178312
- Semantic Scholar
- 3a8edbde1ad77b2aedc833527c5cfe4dc8f73a73
- Cited by
- 1,654
- References
- 45
- Citations by year
- 2026: 13 · 2025: 32 · 2024: 36 · 2023: 38 · 2022: 59 · 2021: 78 · 2020: 52 · 2019: 53 · 2018: 62 · 2017: 62 · 2016: 83 · 2015: 99 · 2014: 80 · 2013: 94 · 2012: 109
- FWCI
- 38.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (2 PO1 MH25642, MH45481)
- National Institute of Mental Health (R37MH045481, P01MH025642, R01MH045481)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- brain-derived neurotrophic factor, antidepressant effects, depression, learned helplessness, forced swim test, hippocampus, dentate gyrus, neurotrophin-3, nerve growth factor, intracerebroventricular infusion
- MeSH terms
- Animals, Behavior, Animal, Depression, Disease Models, Animal, Electroshock, Enzyme Inhibitors, Escape Reaction, Helplessness, Learned, Hippocampus, Immunohistochemistry, Male, Microinjections, Motor Activity, Reaction Time, Spatial Behavior, Proto-Oncogene Proteins c-fos, Rats, Sprague-Dawley, Dentate Gyrus, Brain-Derived Neurotrophic Factor, Mitogen-Activated Protein Kinases, Nerve Growth Factor, Neurotrophin 3, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
